Type and location of fluorescent probes incorporated into the potent mu-opioid peptide [Dmt]DALDA affect potency, receptor selectivity and intrinsic efficacy.
about
Fluorescent approaches for understanding interactions of ligands with G protein coupled receptorsFluorescent mu selective opioid ligands from a mixture based cyclic peptide library.[Dmt(1)]DALDA analogues with enhanced μ opioid agonist potency and with a mixed μ/κ opioid activity profileDesign, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptors.
P2860
Type and location of fluorescent probes incorporated into the potent mu-opioid peptide [Dmt]DALDA affect potency, receptor selectivity and intrinsic efficacy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Type and location of fluoresce ...... tivity and intrinsic efficacy.
@ast
Type and location of fluoresce ...... tivity and intrinsic efficacy.
@en
type
label
Type and location of fluoresce ...... tivity and intrinsic efficacy.
@ast
Type and location of fluoresce ...... tivity and intrinsic efficacy.
@en
prefLabel
Type and location of fluoresce ...... tivity and intrinsic efficacy.
@ast
Type and location of fluoresce ...... tivity and intrinsic efficacy.
@en
P2093
P2860
P1476
Type and location of fluoresce ...... tivity and intrinsic efficacy.
@en
P2093
P2860
P304
P356
10.1111/J.1399-3011.2005.00252.X
P577
2005-06-01T00:00:00Z